Science Explorer Interactive view Map
Company · Maastricht · Netherlands

PathoFinder (Netherlands)

pathofinder.comROR OpenAlex
Research works
27
▲ 55% vs 2013–17
Citations
433
15.9 per fractional work
Top-10% rate
11.0%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: PathoFinder (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.50× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.11× its world share, 0 worksImmunology and Micro…Computer Science: 0.16× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 0 worksEngineeringPhysics and Astronomy: 0.28× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.12× its world share, 0 worksHealth ProfessionsMedicine: 3.20× its world share, 5 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

Which keywords describe research at PathoFinder (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Survival Analysis, Clinical Practice Guidelines, Data Analysis, Cervical Cancer, Gene Expression and Neoadjuvant Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Epidemiology5▲ 5.0×29 topics
  2. Chemotherapy2▲ 12×13 topics
  3. Clinical Practice Guidelines2▲ 15×9 topics
  4. Survival Analysis2▲ 32×6 topics
  5. Cervical Cancer2▲ 73×2 topics
  6. Data Analysis2▲ 22×2 topics
  7. Diagnosis2▲ 6.3×16 topics
  8. Gene Expression2▲ 10×4 topics
  9. Global Burden2▲ 11×4 topics
  10. Human Papillomavirus2▲ 46×3 topics
  11. Neoadjuvant Therapy2▲ 27×5 topics
  12. Immunotherapy2▲ 8.5×9 topics
  13. Breast Cancer1▲ 19×6 topics
  14. Cancer Incidence1▲ 37×2 topics
  15. Cytology Screening1▲ 101×1 topic
  16. HPV Vaccination1▲ 101×1 topic
  17. Biomarkers1▲ 7.7×3 topics
  18. Precision Medicine1▲ 15×4 topics
  19. Genomics1▲ 12×3 topics
  20. Molecular Characterization1▲ 21×4 topics
  21. Treatment1▲ 3.0×11 topics
  22. Chiral Separation1▲ 30×1 topic
  23. Inflammation1▲ 1.57×10 topics
  24. Liquid Chromatography1▲ 25×1 topic
  25. Management1▲ 4.9×8 topics
  26. Mass Spectrometry1▲ 17×1 topic
  27. Metabolomics1▲ 69×1 topic
  28. Quantitative1▲ 31×2 topics
  29. Radiotherapy1▲ 10.0×5 topics
  30. Risk Factors1▲ 3.7×9 topics

Which research topics does PathoFinder (Netherlands) publish most on?

By volume in 2022–2025: Metabolomics and Mass Spectrometry Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects and Cytokine Signaling Pathways and Interactions.

Metabolomics and Mass Sp…1Metabolomics and Mass Spectrometry Studies: 1 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional worksEstrogen and related hor…0Estrogen and related hormone effects: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksOrthopaedic implants and arthroplasty: 0 fractional worksGastric Cancer Management and Outcomes: 0 fractional worksEsophageal Cancer Research and Treatment: 0 fractional worksColorectal Cancer Screening and Detection: 0 fractional works
Molecular BiologyOncologyGeneticsCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
  2. 2 HER2/EGFR in Cancer Research Oncology 0 works
  3. 3 Estrogen and related hormone effects Genetics 0 works
  4. 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 Orthopaedic implants and arthroplasty Surgery 0 works
  8. 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  9. 9 Esophageal Cancer Research and Treatment Surgery 0 works
  10. 10 Colorectal Cancer Screening and Detection Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.0%not open48.0%

World: 28% of research is openly available.

with international co-authors33.0%domestic only67.0%

World: 19% is written across borders.

How has PathoFinder (Netherlands)'s research output changed?

Output in 2018–2022 was 55% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Maastricht

All research institutions in Maastricht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.